Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 9601-9610 of 13616

Page
per page
  1. Dasatinib Monohydrate
    B5954 Dasatinib Monohydrate
    Target: PDGFR|c-Kit|Bcr-Abl|Src
    Summary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.
      ≥25.3 mg/mL
  2. UNC 0631
    B1127 UNC 0631
    Summary: G9a inhibitor
  3. Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium
    B1634 Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium
    Summary: microtubule destabilizing drug, water-soluble
      ≥4.4 mg/mL
  4. (R)-(+)-Tolterodine
    B1033 (R)-(+)-Tolterodine
    Summary: Muscarinic receptor antagonists
      ≥42.4 mg/mL
  5. Detomidine
    B1060 Detomidine
    Summary: α2-adrenergic agonist
      Soluble in DMSO
  6. Mizolastine
    B1551 Mizolastine
    Summary: Histamine H1-receptor antagonist
      insoluble in H2O; ≥21.62 mg/mL
  7. Estradiol valerate
    B1506 Estradiol valerate
    Target: Estrogen and Related Receptors
    Summary: Estrogen receptor agonist
      insoluble in H2O; ≥15.45 mg/mL
  8. IMD 0354
    B1587 IMD 0354
     1 Citation
    Summary: IKKβ inhibitor
      insoluble in H2O; ≥100.8 mg/mL
  9. ML133 HCl
    B2199 ML133 HCl
    Summary: Potassium channel inhibitor for Kir2.1
      insoluble in H2O; ≥15.7 mg/mL
  10. Pergolide mesylate
    B1485 Pergolide mesylate
    Target: D1 and D5 Receptors|D2 Receptors
    Summary: Dopaminergic agonist
      insoluble in EtOH; insoluble in H2O; ≥6.84 mg/mL

Items 9601-9610 of 13616

Page
per page